https://www.urotoday.com/conference-highlights/suo-2022/suo-2022-prostate-cancer/141072-suo-2022-use-of-exogenous-testosterone-in-the-setting-of-screening-active-surveillance-and-after-treatment-of-localized-disease.html
(UroToday.com) At the 2022 Prostate Cancer Session of the Annual Meeting...
In this video, PCRI's Alex asks Mark Scholz, MD, questions from our YouTube comments about radiation and hormone therapy for prostate cancer. Dr. Scholz is a medical oncologist specializing exclusively in prostate cancer.
0:07 What is the risk of developing secondary cancers after radiation...